| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 303,125 | 316,735 | 313,029 | 317,975 | | Cost of Revenue | (360,391) | 165,544 | 194,847 |
-
| | | Gross Profit | 663,516 | 151,191 | 118,182 | 317,975 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 532,000 |
-
|
-
| 187,643 | | Non Recurring | 35,212 | 1,451 | 1,124 | 212 | | Others | 75,993 | 67,853 | 66,458 | 57,854 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 65,619 | 81,887 | 50,600 | 72,266 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 34,424 | 20,657 | 6,808 | (8,551) | | Earnings Before Interest And Taxes | 89,398 | 102,544 | 57,408 | 85,000 | | Interest Expense | 79,382 | 83,673 | 95,379 | 115,762 | | Income Before Tax | 10,016 | 18,871 | (37,971) | (30,762) | | Income Tax Expense | (3,072) | (531) | (22,271) | (1,884) | | Minority Interest | (6,199) |
-
|
-
| (3,493) | | | | Net Income From Continuing Ops | 1,252 | 1,964 | (31,566) | (49,534) | | | Non-recurring Events | | Discontinued Operations | (5,123) |
-
| 2,820 | 4,449 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (10,070) | 1,964 | (28,746) | (45,085) | | Preferred Stock And Other Adjustments | 5,686 | (3,753) | (1,933) |
-
| | | Net Income Applicable To Common Shares | ($4,384) | ($1,789) | ($30,679) | ($45,085) |
|
0.51% Nasdaq 
0.14 (1.08%) 
Income Statement
